This information is disseminated under the sponsorship of the U.S. Department of Transportation
in the interest of information exchange.
The United States Government assumes no Liability for the contents or use thereof.
Tacrine |
| Description |
Tacrine is approved for the treatment of Alzheimer's disease, and was marketed under the trade name Cognex. |
| Therapeutic Low |
0.0010 |
| Therapeutic High |
0.0230 |
| Units |
ug/mL |
| Specimen |
P |
| Half Life Low |
2.00 |
| Half Life High |
4.00 |
| VOD Low |
349.00 |
| VOD High |
0.00 |
| Toxic Level |
0.000 |
| Lethal Level |
0.000 |
| Plasma to Whole Blood ratio |
0.00 |
| Warnings |
|